Latest News about YMAB
Recent news which mentions YMAB
ON Semiconductor, Global Payments And Other Big Losers From Monday
November 01, 2022
From Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
November 01, 2022
From Benzinga
Analysts Slash Y-mAbs Therapeutics Price Targets As Uncertainty Looms Over Neuroblastoma Hopeful
October 31, 2022
Tickers
YMAB
From Benzinga
S&P 500 Down 0.5%; Crude Oil Falls Sharply
October 31, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
October 31, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 31, 2022
From Benzinga
Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
October 31, 2022
From Benzinga
Nasdaq Down Over 100 Points; Chicago PMI Drops Further
October 31, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
From Benzinga
US Stocks Start Week On Lower Note; Dow Dips Over 200 Points
October 31, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 31, 2022
From Benzinga
TuSimple, Y-mAbs Therapeutics And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
October 31, 2022
From Benzinga
From InvestorPlace
Why Quanergy Systems Shares Are Trading Sharply Lower; Here Are 28 Stocks Moving Premarket
October 31, 2022
From Benzinga
FDA's AdComm Gives Thumbs Down To Pediatric Cancer Therapy
October 31, 2022
Tickers
YMAB
From Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
October 28, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 27, 2022
From Benzinga
Why UserTesting Shares Are Trading Higher By Around 93%? Here Are 53 Stocks Moving In Thursday's Mid-Day Session
October 27, 2022
From Benzinga
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
October 27, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 26, 2022
From Benzinga
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
FDA Advisory Committee Meeting Scheduled For October 28, 2022 To Review Y-mAbs' Refiling For Omburtamab
September 01, 2022
Tickers
YMAB
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 30, 2022
From Benzinga
From Benzinga
Earnings Scheduled For August 8, 2022
August 08, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.